152 related articles for article (PubMed ID: 11597315)
1. Recent advances in technologies for the detection of occult metastatic cells in bone marrow of breast cancer patients.
Braun S; Harbeck N
Breast Cancer Res; 2001; 3(5):285-8. PubMed ID: 11597315
[TBL] [Abstract][Full Text] [Related]
2. Implications of occult metastatic cells for systemic cancer treatment in patients with breast or gastrointestinal cancer.
Braun S; Rosenberg R; Thorban S; Harbeck N
Semin Surg Oncol; 2001 Jun; 20(4):334-46. PubMed ID: 11747276
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of proliferative potential of occult metastatic cells in bone marrow of patients with breast cancer.
Pierga JY; Bonneton C; Magdelénat H; Vincent-Salomon A; Nos C; Pouillart P; Thiery JP
Br J Cancer; 2003 Aug; 89(3):539-45. PubMed ID: 12888827
[TBL] [Abstract][Full Text] [Related]
4. Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer.
Braun S; Pantel K; Müller P; Janni W; Hepp F; Kentenich CR; Gastroph S; Wischnik A; Dimpfl T; Kindermann G; Riethmüller G; Schlimok G
N Engl J Med; 2000 Feb; 342(8):525-33. PubMed ID: 10684910
[TBL] [Abstract][Full Text] [Related]
5. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of micrometastatic bone marrow involvement.
Braun S; Pantel K
Breast Cancer Res Treat; 1998; 52(1-3):201-16. PubMed ID: 10066083
[TBL] [Abstract][Full Text] [Related]
7. [Micrometastatic cells in the bone marrow of patients with breast carcinoma].
Diel IJ; Solomayer EF; Bastert G
Radiologe; 2000 Aug; 40(8):681-7. PubMed ID: 11006937
[TBL] [Abstract][Full Text] [Related]
8. Detection of occult tumour cells in bone marrow and blood in breast cancer patients--methods and clinical significance.
Kvalheim G
Acta Oncol; 1996; 35 Suppl 8():13-8. PubMed ID: 9073044
[TBL] [Abstract][Full Text] [Related]
9. The fate and prognostic value of occult metastatic cells in the bone marrow of patients with breast carcinoma between primary treatment and recurrence.
Janni W; Hepp F; Rjosk D; Kentenich C; Strobl B; Schindlbeck C; Hantschmann P; Sommer H; Pantel K; Braun S
Cancer; 2001 Jul; 92(1):46-53. PubMed ID: 11443608
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow and lymph node assessment for minimal residual disease in patients with breast cancer.
Diel IJ; Cote RJ
Cancer Treat Rev; 2000 Feb; 26(1):53-65. PubMed ID: 10660491
[TBL] [Abstract][Full Text] [Related]
11. Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction.
Datta YH; Adams PT; Drobyski WR; Ethier SP; Terry VH; Roth MS
J Clin Oncol; 1994 Mar; 12(3):475-82. PubMed ID: 7509852
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies detect occult breast carcinoma metastases in the bone marrow of patients with early stage disease.
Cote RJ; Rosen PP; Hakes TB; Sedira M; Bazinet M; Kinne DW; Old LJ; Osborne MP
Am J Surg Pathol; 1988 May; 12(5):333-40. PubMed ID: 3364618
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of occult metastatic cells in bone marrow of breast cancer patients.
Braun S; Pantel K
Oncologist; 2001; 6(2):125-32. PubMed ID: 11306724
[TBL] [Abstract][Full Text] [Related]
14. Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status.
Diel IJ; Kaufmann M; Costa SD; Holle R; von Minckwitz G; Solomayer EF; Kaul S; Bastert G
J Natl Cancer Inst; 1996 Nov; 88(22):1652-8. PubMed ID: 8931609
[TBL] [Abstract][Full Text] [Related]
15. Bone Marrow Metastasis Is an Early Stage of Bone Metastasis in Breast Cancer Detected Clinically by F18-FDG-PET/CT Imaging.
Al-Muqbel KM
Biomed Res Int; 2017; 2017():9852632. PubMed ID: 28884133
[TBL] [Abstract][Full Text] [Related]
16. Relative microvessel area of the primary tumour, and not lymph node status, predicts the presence of bone marrow micrometastases detected by reverse transcriptase polymerase chain reaction in patients with clinically non-metastatic breast cancer.
Benoy IH; Salgado R; Elst H; Van Dam P; Weyler J; Van Marck E; Scharpé S; Vermeulen PB; Dirix LY
Breast Cancer Res; 2005; 7(2):R210-9. PubMed ID: 15743502
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of disseminated tumor cells as detected by quantitative real-time reverse-transcriptase polymerase chain reaction in patients with breast cancer.
Benoy IH; Elst H; Philips M; Wuyts H; Van Dam P; Scharpé S; Van Marck E; Vermeulen PB; Dirix LY
Clin Breast Cancer; 2006 Jun; 7(2):146-52. PubMed ID: 16800974
[TBL] [Abstract][Full Text] [Related]
18. Increased serum interleukin-8 in patients with early and metastatic breast cancer correlates with early dissemination and survival.
Benoy IH; Salgado R; Van Dam P; Geboers K; Van Marck E; Scharpé S; Vermeulen PB; Dirix LY
Clin Cancer Res; 2004 Nov; 10(21):7157-62. PubMed ID: 15534087
[TBL] [Abstract][Full Text] [Related]
19. Detection of tumor cells in bone marrow of patients with primary breast cancer: a prognostic factor for distant metastasis.
Diel IJ; Kaufmann M; Goerner R; Costa SD; Kaul S; Bastert G
J Clin Oncol; 1992 Oct; 10(10):1534-9. PubMed ID: 1403032
[TBL] [Abstract][Full Text] [Related]
20. [Detection of tumor cells in bone marrow: a deciding aid for adjuvant therapy in node negative patients with breast cancer. Concept for a multicenter study and results of the pilot phase].
Funke I; Fries S; Jauch KW
Chirurg; 1991 Nov; 62(11):805-9. PubMed ID: 1769261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
